
TWST
Twist Bioscience
$86.54
−$3.73 (−4.13%)Jul 27, 2026
Key metrics
The numbers that frame TWST today
- Market cap
- $5.39B
- P/E (TTM)
- -66.3
- EV / FCF
- -56.5
- Gross margin
- 52.1%
- EV / Sales
- 13.1
- ROIC
- -20.3%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $23.30
- 52wk High
- $105.47
Growth
Revenue and earnings trend for TWST
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TWST
Is Twist Bioscience a good buy?
Yes. Twist Bioscience has excellent momentum, and it outweighs the poor quality here. Growth looks strong, which supports the long-term business case. We think Twist Bioscience is selling at a high price, which cuts against the buy case.
What is the market capitalization of TWST?
Twist Bioscience's market capitalization is $5.39B.
What is the P/E ratio for TWST stock?
Twist Bioscience's current P/E ratio is -66.3.
What is the 52-week high for TWST stock?
The 52-week high for Twist Bioscience is $105.47. The current close of $86.54 is 17.9% below that high.
What is the 52-week low for TWST stock?
The 52-week low for Twist Bioscience is $23.30. The current close of $86.54 is 271.4% above that low.
Does TWST stock pay dividends?
Twist Bioscience does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TWST?
Twist Bioscience's Debt / Equity ratio is 0.24.